J. Goldman & Co LP Acquires New Shares in Varex Imaging $VREX

J. Goldman & Co LP acquired a new position in shares of Varex Imaging (NASDAQ:VREX) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 595,844 shares of the company’s stock, valued at approximately $6,215,000. J. Goldman & Co LP owned 1.42% of Varex Imaging at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in VREX. Pzena Investment Management LLC acquired a new stake in Varex Imaging during the 2nd quarter worth approximately $45,312,000. BlackRock Inc. acquired a new position in shares of Varex Imaging in the second quarter valued at approximately $40,624,000. Rice Hall James & Associates LLC acquired a new position in shares of Varex Imaging in the second quarter valued at approximately $15,080,000. LSV Asset Management increased its position in shares of Varex Imaging by 210.7% during the fourth quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock worth $14,496,000 after acquiring an additional 843,805 shares in the last quarter. Finally, Millennium Management LLC increased its position in shares of Varex Imaging by 119.8% during the third quarter. Millennium Management LLC now owns 913,169 shares of the company’s stock worth $11,323,000 after acquiring an additional 497,650 shares in the last quarter.

Wall Street Analyst Weigh In

Several research firms recently commented on VREX. CJS Securities cut shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a research report on Monday, August 17th. Sidoti reiterated a “neutral” rating and set a $19.00 target price on shares of Varex Imaging in a report on Monday, August 10th. B. Riley Financial downgraded Varex Imaging from a “buy” rating to a “hold” rating in a research note on Monday, August 10th. Weiss Ratings upgraded Varex Imaging from a “sell (d-)” rating to a “sell (d+)” rating in a report on Tuesday, August 11th. Finally, Oppenheimer cut Varex Imaging from an “outperform” rating to a “market perform” rating in a research report on Monday, August 10th. Six analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Varex Imaging has a consensus rating of “Reduce” and a consensus target price of $16.88.

Varex Imaging Price Performance

NASDAQ VREX opened at $18.50 on Wednesday. The firm’s 50 day moving average is $12.70 and its 200-day moving average is $11.89. The company has a quick ratio of 1.53, a current ratio of 3.38 and a debt-to-equity ratio of 0.64. The company has a market capitalization of $778.85 million, a PE ratio of 35.58 and a beta of 0.89. Varex Imaging has a 12-month low of $9.09 and a 12-month high of $18.63.

Varex Imaging (NASDAQ:VREX) last announced its earnings results on Monday, August 10th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.21 by $0.10. The business had revenue of $210.50 million during the quarter, compared to analysts’ expectations of $215.50 million. Varex Imaging had a net margin of 2.55% and a return on equity of 9.19%. Equities research analysts anticipate that Varex Imaging will post 0.98 earnings per share for the current fiscal year.

Varex Imaging Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.